Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
9.96
-0.19 (-1.87%)
Jul 3, 2025, 1:00 PM - Market closed
Organon & Co. Stock Forecast
Stock Price Forecast
The 4 analysts that cover Organon & Co. stock have a consensus rating of "Hold" and an average price target of $18, which forecasts a 80.72% increase in the stock price over the next year. The lowest target is $10 and the highest is $24.
Price Target: $18 (+80.72%)
Analyst Consensus: Hold
* Price targets were last updated on May 15, 2025.
Analyst Ratings
The average analyst rating for Organon & Co. stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $24 → $18 | Buy | Maintains | $24 → $18 | +80.72% | May 15, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $10 | Hold | Maintains | $15 → $10 | +0.40% | May 5, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +50.60% | Apr 9, 2025 |
| Barclays | Barclays | Buy Maintains $26 → $24 | Buy | Maintains | $26 → $24 | +140.96% | Feb 14, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $16 | Hold | Maintains | $17 → $16 | +60.64% | Feb 14, 2025 |
Financial Forecast
Revenue This Year
6.29B
from 6.40B
Decreased by -1.84%
Revenue Next Year
6.36B
from 6.29B
Increased by 1.11%
EPS This Year
3.90
from 3.33
Increased by 17.13%
EPS Next Year
4.12
from 3.90
Increased by 5.74%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.6B | 6.7B | 6.8B | ||
| Avg | 6.3B | 6.4B | 6.4B | ||
| Low | 6.0B | 6.0B | 6.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.1% | 6.7% | 7.7% | ||
| Avg | -1.8% | 1.1% | 1.2% | ||
| Low | -5.7% | -4.3% | -5.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.23 | 4.57 | 5.02 | ||
| Avg | 3.90 | 4.12 | 4.35 | ||
| Low | 3.61 | 3.72 | 3.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.1% | 17.1% | 21.7% | ||
| Avg | 17.1% | 5.7% | 5.6% | ||
| Low | 8.3% | -4.5% | -8.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.